Spelling suggestions: "subject:"7nitroindazole"" "subject:"7dinitroindazole""
1 |
Efeitos do 7-nitroindazole, um inibidor da sintase neuronal do oxido nitrico (nNOS), sobre o condiciomaneto contextural em pombos / Effect of neuronal nitric oxide synthase inhibitor 7-nitroindazole on contextual fear memory in pigeonsDenadai, Magda Aline 29 August 2008 (has links)
Orientador: Elenice Aparecida de Moraes Ferrari / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-11T20:16:54Z (GMT). No. of bitstreams: 1
Denadai_MagdaAline_M.pdf: 823511 bytes, checksum: 1887972f9e5047fecbd7195247b586a8 (MD5)
Previous issue date: 2008 / Resumo: O óxido nítrico (NO), um neurotransmissor não convencional, tem papel importante
em processos neurobiológicos de comportamento e de memória. Sua síntese é mediada
por três isoformas de sintase do óxido nítrico (NOS): a neuronal (nNOS), a endotelial
(eNOS) e induzível (iNOS). Este trabalho analisou o efeito do 7-nitroindazole (7-NI), um
inibidor seletivo da nNOS, no condicionamento clássico aversivo em pombos. Foram
usados 4 grupos: tratados com 7-NI (grupo 7-nitroindazole; G7-NI, n=5), tratados com
óleo de amendoim (grupo veículo; GV, n=5), controle/sem tratamento (grupo controle; GC,
n=5) e grupo não tratado/não condicionado (grupo manipulação; GM, n=5). A
administração i.p. de 7-NI (25 mg/kg), ou do óleo de amendoim foi feita imediatamente
após o treinamento. O G7-NI, o GV e o GC receberam três associações som-choque (5°,
10° e 15º minutos) numa sessão de 20 min. O teste a o contexto foi realizado 24 horas
depois. As sessões foram gravadas para posterior transcrição e análise comportamental.
A ocorrência da resposta de congelamento durante o treino não diferiu entre os grupos
(p>0,05), mas durante o teste foi menor para o G7-NI em comparação ao treino (p<0.01) e
aos demais grupos no teste (p<0.001). A atividade da NOS dependente de Ca++ no
hipocampo foi menor no G7-NI do que nos outros grupos (p<0,01). Análise por Western
blot indicou aumento na expressão de nNOS no G7-NI (p<0,05). A administração
sistêmica de 7-NI teve um efeito amnésico sobre a memória contextual aversiva,
indicando que a atividade da NOS dependente de Ca++ é importante para os processos de
condicionamento clássico aversivo em pombos. / Abstract: Nitric oxide (NO) is an unsual neurotransmitter that plays an important role in
neurobiological functions underlying behavior and memory. NO synthesis and release can
be mediated by three isoforms of NO synthases (NOS): neuronal (nNOS), endothelial
(eNOS) and inducible (iNOS). This study examined the effect of 7-nitroindazole (7-NI), a
selective nNOS inhibitor, on contextual fear conditioning in pigeons. Four groups of
pigeons were used: treated with 7-NI (7-NI; n=5), treated with peanut oil (Vehicle; n=5),
non treated controls (Control; n=5) and non treated and no-trained controls (Non-trained;
n=5). Treatment consisted in 7-NI (25 mg/kg; i.p.) or vehicle (peanut oil) administration,
immediately after training. All the animals were trained in one 20 min session during which
three tone-shock pairings (5th, 10th and 15th minutes) were presented. The test to the
context was conducted 24h later. Behavioral categories were analyzed through the
transcription of video-tapes of the sessions. The groups 7-NI, Vehicle and Control showed
no significant differences in freezing during the conditioning session (p>0.05). During the
test to the context the group 7-NI expressed significantly lower freezing as compared to
Vehicle and Control (p<0.05). The 7-NI pigeons showed lower hippocampal activity of Ca++
dependent-NOS than Vehicle and Control groups (p<0.01). Western blot analysis indicated
significant increase in nNOS expression (p<0.05). The systemic administration of 7-NI
induced amnestic effects on contextual fear memory that evidence that Ca++-dependent
NOS activity is required for fear conditioning in pigeons. / Mestrado / Fisiologia / Mestre em Biologia Funcional e Molecular
|
2 |
Participação da sintase neuronal de óxido nítrico (nNOS) na consolidação e reconsolidação da memória do condicionamento clássico aversivo em pombos (Columba livia) / Participation of neuronal nitric oxide synthase (nNOS) in consolidation and reconsolidation of classical fear conditioning in pigeons (Columba livia)Faria, Larissa Oliveira Melloni de, 1985- 23 August 2018 (has links)
Orientador: Elenice Aparecida de Moraes Ferrari / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-23T06:24:39Z (GMT). No. of bitstreams: 1
Faria_LarissaOliveiraMellonide_M.pdf: 1121073 bytes, checksum: 5a3108ca0447b5fae98988b4611d7616 (MD5)
Previous issue date: 2013 / Resumo: O óxido nítrico (NO) é um neurotransmissor não convencional o qual tem papel importante em processos neurobiológicos de comportamento e de memória. Sua síntese é mediada por três isoformas de sintase do óxido nítrico (NOS): a neuronal (nNOS), a endotelial (eNOS) e a induzível (iNOS). Este trabalho investigou os efeitos da administração do 7- nitroindazol (7-NI), inibidor preferencial da nNOS, na consolidação e reconsolidação da memória do condicionamento clássico aversivo. Pombos adultos foram atribuídos a 5 grupos: Foram usados 5 grupos: grupo 7-nitroindazole (7-NI) (100nmol/0.5?/l; DMSO (20%), NaOH (50mM) e Tween-80 (16%) diluído em PBS; i.c.v.), grupo veículo (VEIC) (0,5?/l; DMSO (20%), NaOH (50mM) e Tween-80 (16%) diluído em PBS, i.c.v.), grupo condicionado/não tratado (COND), grupo contexto/não-tratado (CONT) e grupo não tratado/não condicionado (NÄIVE). Sete dias após implante de microcânula intracerebroventricular (i.c.v.), ocorreu o condicionamento com três associações contextochoque numa sessão de 20 min. O teste e o re-teste consistiram na re-exposição ao contexto do condicionamento por 5 min. O intervalo entre sessões foi de 24h. A administração de 7-NI ou do veículo ocorreu imediatamente após o treino (Experimento 1) ou após o re-teste (Experimento 2). A atividade enzimática da NOS dependente e independente de Ca2+ e da expressão protéica da nNOS foram realizadas no tecido hipocampal. No Experimento 1, a ocorrência de congelamento no teste do 7-NI foi menor do que no treino (p<0.01) e no teste do COND e VEIC (p < 0.001). A atividade da NOS dependente de Ca++ no 7-NI foi menor do que no COND e VEIC (p<0,01), mas não diferiu do CONT e do NÄIVE. A expressão protéica de nNOS não diferiu entre os grupos (p<0,05). No Experimento 2, houve diminuição dos comportamentos defensivos, incluindo o congelamento, no re-teste do 7-NI comparado com VEIC e COND (p<0.05), mas os grupos não diferiram quanto à atividade de NOS dependente de Ca2+ ou à expressão protéica da nNOS. Conclui-se que o 7-NI interferiu na consolidação e a reconsolidação da memória, indicando a ativação da via de sinalização do óxido nítrico no hipocampo em processos da memória de medo condicionado ao contexto em pombos / Abstract: Nitric oxide (NO) is an unconventional neurotransmitter which plays an important role in neurobiological processes of behavior and memory. Its synthesis is mediated by three isoforms of nitric oxide synthase (NOS): the neuronal (nNOS), the endothelial (eNOS) and the inducible (iNOS). This study investigated the effects of the administration of 7- nitroindazole (7-NI), a preferential nNOS inhibitor, in the consolidation and reconsolidation of aversive classical conditioning memory. Adult male pigeons were assigned to 5 groups: 7-nitroindazole, 7-NI (100nmol/0.5?/l; DMSO (20%), NaOH (50 mM) and Tween-80 (16%) diluted in PBS; i.c.v.) Vehicle group; VEH (0.5 ? / L; DMSO (20%), NaOH (50 mM) and Tween-80 (16%) diluted in PBS; i.c.v.), conditioning/non-treated group (COND), context/non-treated group (CONT) and non-conditioning/non-treated group (NÄIVE). Seven days after implantation of intracerebral ventricular (i.c.v.) microcannula the conditioning occurred with three context-shock associations in a session of 20 min. During the testing and retesting sessions pigeons were reexposed to the conditioning context for 5 min. The between sessions interval was 24h. Administration of 7-NI or vehicle occurred immediately after training (Experiment 1) or after testing (Experiment 2). The enzymatic activity of Ca2+ dependent and independent NOS and protein expression of nNOS in the hippocampus tissue were carried out following the behavioral test or retest. In Experiment 1, the occurrence of freezing in the testing session of 7-NI group was lower than in the training (p <0.01) and the testing sessions of COND and VEH groups (p <0.001). The activity of Ca2+ dependent NOS in the 7-NI group was lower than in COND and VEH groups (p <0.01) but did not differ from CONT and NÄIVE groups. The nNOS protein expression in the hippocampus did not differ among the different groups (p<0.05). In Experiment 2, there was a decrease of defensive behaviors, which include freezing, in the retest of the 7-NI compared with VEH and COND groups (p <0.05), but the groups did not differ in the activity of Ca2+ dependent NOS or the protein expression of nNOS. We conclude that 7-NI interfered on the consolidation and reconsolidation of memory, indicating activation of the nitric oxide signaling pathway in the hippocampus and in memory processes of conditioned fear context in pigeons / Mestrado / Fisiologia / Mestra em Biologia Funcional e Molecular
|
3 |
7-Nitroindazole Enhances Amphetamine-Evoked Dopamine Release in Rat Striatum. An in Vivo Microdialysis and Voltammetric StudyNowak, P., Brus, R., Oswiecimska, J., Sokola, A., Kostrzewa, R. M. 14 July 2002 (has links) (PDF)
The intracellular second messenger nitric oxide (NO) is implicated in a variety of physiological functions, including release and uptake of dopamine (DA). In the described study, in vivo microdialysis and differential pulse voltammetric techniques were used to determine the involvement of NO in release of DA and its metabolites (dihydroxyphenylalanine, DOPAC; homovanillic acid, HVA) in neostriatum of freely moving rats. While the NO donor molsidomine (30.0 mg/kg; MOLS) and neuronal NO synthase- (nNOS-) inhbitor 7-nitroindazole (10.0 mg/kg; 7-NI) had no effect on the basal in vivo microdialysate level of DA, 7-NI specifically enhanced D,L-amphetamine- (1.0 mg/kg i.p.; AMPH) evoked release of DA. Basal or AMPH effects on DOPAC and HVA levels were not influenced by MOLS or 7-NI. Findings indicate that nitrergic systems have an important role in mediating effects of AMPH on dopaminergic systems.
|
4 |
The involvement of nitric oxide in a rodent model of post-traumatic stress disorder / Frasia OosthuizenOosthuizen, Frasia January 2003 (has links)
Post-traumatic stress disorder (PTSD), an anxiety disorder, may develop after
experiencing or witnessing a severe traumatic event. Characteristic symptoms
include hyper arousal and amnesic symptoms, while volume reductions in the
hippocampus of these patients appear correlated with illness severity and the
degree of cognitive deficit. Stress-induced increases in plasma cortisol have been
implicated in this apparent atrophy of the hippocampus, although, clinical studies
have described a marked suppression of plasma cortisol in PTSD. Given this
hypocortisolemia, the basis for hippocampal neuro degeneration and cognitive
decline remains unclear.
While stress-related hippocampal structural changes have been linked to the
neurotoxic effects of glucocorticoids and glutamate. NMDA-NO pathways have
been found to play a causal role in anxiety-related behaviours.
Prior exposure to trauma is an important risk factor for PTSD. In most instances the
disorder becomes progressively worse over time, possibly with a delayed onset,
suggesting a role for sensitization. In this study a time-dependent sensitization
(TDS) model was used to induce PTSD-like sequelae in male Spraque-Dawley rats.
The TDS-model is based on exposure to acute stressors, with a reminder of the
trauma, in the form of re-exposure to one of the acute stressor, seven days later.
NOS-activity, NMDA receptor parameters (Bmax and Kd) and GABA levels in the
hippocampus of rats, as well as plasma corticosterone levels were determined 21
days after exposure to the TDS-model.
Increased levels of corticosterone were measured after exposure to acute stress,
but these levels were found to decrease below basal levels 21 days after the re-exposure,
thus mimicking glucocorticoid levels in patients with PTSD. These
findings may also imply that the increase in glucocorticoid levels after stress
exposure is only the initial step in a cascade of events leading to neuronal
damage in the hippocampus.
This study also found that stress-restress evoked a long-lasting increase in
hippocampal NOS activity that was accompanied by a reactive down-regulation
of hippocampal NMDA receptors and dysregulation of inhibitory GABA pathways.
Subsequently, animals were chronically treated with certain pharmacological
agents prior to exposure to the TDS-model to determine possible approaches for
inhibiting the induction of PTSD. Pre-treatment with fluoxetine, currently indicated
in the treatment of PTSD. and the nNOS inhibitor, 7-nitroindazole, had no effect on
the increased NOS activity measured 21 days afler exposure to the TDS-model.
Pre-treatment with the iNOS inhibitor, aminoguanidine, however, resulted in
inhibition of the observed increase in hippocampal NOS-activity, implicating a
possible role for the iNOS isoform in the etiology of PTSD.
Treatment with ketoconazole, an inhibitor of glucoccfticoid synthesis, resulted in
inhibition of the increase in NOS-activity observed after exposure to TDS-stress, thus
indicating a possible link between stress glucocorticoid-release and NO synthesis.
These perturbations may have importance in explaining the increasing evidence
for stress-related hippocampal degenerative pathology and cognitive deficits
seen in patients with PTSD. Uncovering and understanding the role of NO in PTSD
will hopefully lead to the development of selective therapeutic agents in disorders
like PTSD. as well as providing a better understanding of basic processes
underlying normal and pathological neuronal functions in PTSD. / Thesis (Ph.D. (Pharmacology))--North-West University, Potchefstroom Campus, 2004.
|
5 |
Investigating the role of the NO-cGMP pathway in an animal model of posttraumatic stress disorder (PTSD) / Tanya BothmaBothma, Tanya January 2004 (has links)
Posttraumatic stress disorder (PTSD) is a severe anxiety disorder characterised by
hypothalamic-pituitary-adrenal (HPA)-axis abnormalities, hyperarousal, anxiety,
flashbacks of trauma memories and avoidance. Increasing evidence is now
accumulating that the disorder is also associated with shrinkage of the hippocampus
and cognitive dysfunction that may have its origin in stress-induced excitotoxicity.
Animal studies have indeed highlighted a potential role of the excitotoxic glutamatenitric
oxide (NO) pathway in the stress response. Since PTSD appears to be an
illness that progresses and worsens over time after an initial severe traumatic event,
this study has used an animal model that emphasises repeated trauma to investigate
the effect of stress on hippocampal NO synthase (NOS) activity, the release of the
nitrogen oxide metabolites of NO (NOx), and also the evoked release of cGMP.
Furthermore, the modulation and dependency of these responses on glutamate, NO
and cGMP activity using drugs selective for these targets, will also be investigated.
Rats (n=10/group) were exposed to repeated stress together with saline or drug
administration immediately after the stress procedure and continuing for one week
post-stress. The animals were then sacrificed for assay of hippocampal NOS activity,
NO, and cGMP accumulation. Animals received either the glutamate-NMDA receptor
antagonist, memantine (MEM;5mg/kg ip/d), the neuronal NOS selective inhibitor, 7-
nitroindazole monosodium salt (7-NINA;20mg/kg ip/d), the cGMP-specific PDE
inhibitor, sildenafil (SIL;10mg/kg ip/d) or the NFkb antagonist, pyrollidine
dithiocarbamate (PDTC;70mg/kg ip/d). The latter inhibits the nuclear transcription
factor, NFkb, responsible for inducing the expression of iNOS, while it also appears
to mediate the glutamatergic actions on NOS expression,
Stress significantly increased hippocampal NOS activity, as well as significantly
increased hippocampal cGMP and NO, levels. These increases were blocked by pretreatment
with either PDTC or 7-NINA, while memantine was without effect. Sildenafil
significantly augmented stress induced NO, accumulation, as well as cGMP.
although the latter failed to reach significance. 7-NINA and memantine significantly
blocked the increase in cGMP evoked by time-dependent sensitisation (TDS)-stress,
with PDTC attenuating this response, but not significantly. Additionally, administration
of each drug separately for seven days without exposure to stress, did not evoke
significant changes in NOx levels, compared to the control group. However,
significant increases in cGMP levels, compared to the control group, were found with
all four drugs.
Repeated trauma therefore activates the NO-cGMP pathway, possibly involving
actions on both nNOS and iNOS. The NMDA receptor appears less involved after
chronic repeated stress, and may have limited therapeutic implications. Sub-cellular
NO-modulation, however, may represent an important therapeutic strategy in
preventing the effects of severe stress and in treating PTSD. / Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2005.
|
6 |
The involvement of nitric oxide in a rodent model of post-traumatic stress disorder / Frasia OosthuizenOosthuizen, Frasia January 2003 (has links)
Post-traumatic stress disorder (PTSD), an anxiety disorder, may develop after
experiencing or witnessing a severe traumatic event. Characteristic symptoms
include hyper arousal and amnesic symptoms, while volume reductions in the
hippocampus of these patients appear correlated with illness severity and the
degree of cognitive deficit. Stress-induced increases in plasma cortisol have been
implicated in this apparent atrophy of the hippocampus, although, clinical studies
have described a marked suppression of plasma cortisol in PTSD. Given this
hypocortisolemia, the basis for hippocampal neuro degeneration and cognitive
decline remains unclear.
While stress-related hippocampal structural changes have been linked to the
neurotoxic effects of glucocorticoids and glutamate. NMDA-NO pathways have
been found to play a causal role in anxiety-related behaviours.
Prior exposure to trauma is an important risk factor for PTSD. In most instances the
disorder becomes progressively worse over time, possibly with a delayed onset,
suggesting a role for sensitization. In this study a time-dependent sensitization
(TDS) model was used to induce PTSD-like sequelae in male Spraque-Dawley rats.
The TDS-model is based on exposure to acute stressors, with a reminder of the
trauma, in the form of re-exposure to one of the acute stressor, seven days later.
NOS-activity, NMDA receptor parameters (Bmax and Kd) and GABA levels in the
hippocampus of rats, as well as plasma corticosterone levels were determined 21
days after exposure to the TDS-model.
Increased levels of corticosterone were measured after exposure to acute stress,
but these levels were found to decrease below basal levels 21 days after the re-exposure,
thus mimicking glucocorticoid levels in patients with PTSD. These
findings may also imply that the increase in glucocorticoid levels after stress
exposure is only the initial step in a cascade of events leading to neuronal
damage in the hippocampus.
This study also found that stress-restress evoked a long-lasting increase in
hippocampal NOS activity that was accompanied by a reactive down-regulation
of hippocampal NMDA receptors and dysregulation of inhibitory GABA pathways.
Subsequently, animals were chronically treated with certain pharmacological
agents prior to exposure to the TDS-model to determine possible approaches for
inhibiting the induction of PTSD. Pre-treatment with fluoxetine, currently indicated
in the treatment of PTSD. and the nNOS inhibitor, 7-nitroindazole, had no effect on
the increased NOS activity measured 21 days afler exposure to the TDS-model.
Pre-treatment with the iNOS inhibitor, aminoguanidine, however, resulted in
inhibition of the observed increase in hippocampal NOS-activity, implicating a
possible role for the iNOS isoform in the etiology of PTSD.
Treatment with ketoconazole, an inhibitor of glucoccfticoid synthesis, resulted in
inhibition of the increase in NOS-activity observed after exposure to TDS-stress, thus
indicating a possible link between stress glucocorticoid-release and NO synthesis.
These perturbations may have importance in explaining the increasing evidence
for stress-related hippocampal degenerative pathology and cognitive deficits
seen in patients with PTSD. Uncovering and understanding the role of NO in PTSD
will hopefully lead to the development of selective therapeutic agents in disorders
like PTSD. as well as providing a better understanding of basic processes
underlying normal and pathological neuronal functions in PTSD. / Thesis (Ph.D. (Pharmacology))--North-West University, Potchefstroom Campus, 2004.
|
7 |
Investigating the role of the NO-cGMP pathway in an animal model of posttraumatic stress disorder (PTSD) / Tanya BothmaBothma, Tanya January 2004 (has links)
Posttraumatic stress disorder (PTSD) is a severe anxiety disorder characterised by
hypothalamic-pituitary-adrenal (HPA)-axis abnormalities, hyperarousal, anxiety,
flashbacks of trauma memories and avoidance. Increasing evidence is now
accumulating that the disorder is also associated with shrinkage of the hippocampus
and cognitive dysfunction that may have its origin in stress-induced excitotoxicity.
Animal studies have indeed highlighted a potential role of the excitotoxic glutamatenitric
oxide (NO) pathway in the stress response. Since PTSD appears to be an
illness that progresses and worsens over time after an initial severe traumatic event,
this study has used an animal model that emphasises repeated trauma to investigate
the effect of stress on hippocampal NO synthase (NOS) activity, the release of the
nitrogen oxide metabolites of NO (NOx), and also the evoked release of cGMP.
Furthermore, the modulation and dependency of these responses on glutamate, NO
and cGMP activity using drugs selective for these targets, will also be investigated.
Rats (n=10/group) were exposed to repeated stress together with saline or drug
administration immediately after the stress procedure and continuing for one week
post-stress. The animals were then sacrificed for assay of hippocampal NOS activity,
NO, and cGMP accumulation. Animals received either the glutamate-NMDA receptor
antagonist, memantine (MEM;5mg/kg ip/d), the neuronal NOS selective inhibitor, 7-
nitroindazole monosodium salt (7-NINA;20mg/kg ip/d), the cGMP-specific PDE
inhibitor, sildenafil (SIL;10mg/kg ip/d) or the NFkb antagonist, pyrollidine
dithiocarbamate (PDTC;70mg/kg ip/d). The latter inhibits the nuclear transcription
factor, NFkb, responsible for inducing the expression of iNOS, while it also appears
to mediate the glutamatergic actions on NOS expression,
Stress significantly increased hippocampal NOS activity, as well as significantly
increased hippocampal cGMP and NO, levels. These increases were blocked by pretreatment
with either PDTC or 7-NINA, while memantine was without effect. Sildenafil
significantly augmented stress induced NO, accumulation, as well as cGMP.
although the latter failed to reach significance. 7-NINA and memantine significantly
blocked the increase in cGMP evoked by time-dependent sensitisation (TDS)-stress,
with PDTC attenuating this response, but not significantly. Additionally, administration
of each drug separately for seven days without exposure to stress, did not evoke
significant changes in NOx levels, compared to the control group. However,
significant increases in cGMP levels, compared to the control group, were found with
all four drugs.
Repeated trauma therefore activates the NO-cGMP pathway, possibly involving
actions on both nNOS and iNOS. The NMDA receptor appears less involved after
chronic repeated stress, and may have limited therapeutic implications. Sub-cellular
NO-modulation, however, may represent an important therapeutic strategy in
preventing the effects of severe stress and in treating PTSD. / Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2005.
|
8 |
Farmakologické ovlivnění neurologického deficitu u modelu fokální mozkové ischémie u potkana / Neurological deficit after focal cerebral ischemia in rat - pharmacological interventionEliášová, Karolína January 2020 (has links)
Title: Neurological deficit after focal cerebral ischemia in rats - pharmacological intervention Objectives: The goal of the thesis was to determine the effect of 7-nitroindazole, a selective inhibitor of neuronal nitric oxide synthase, after focal ischemic stroke in rats. Methods: Twenty adult male Wistar rats were used in this experiment. The rats were randomly divided into four groups: ischemic stroke was given to half of them, the rest were sham operated. 10 animals were given 7-nitroindazole (25mg/kg) to protect neuronal ischemic brain damage. After a few weeks the rats were tested with a set of behavioral tests: Ladder rung walking test, Bar holding test, Rotarod test and Open field test. To evaluate the volume of brain damage the stereotactic method was used. The brain sections were cut and compared with atlas. This study was supported by Institute of Physiology, Academy of Sciences ČR in Prague. Results: The present results show that the 7-nitroindazole has no side effects on healthy rats. The long-term effect on rats after ischemic stroke was not proved. There were a few positive trends observed such as an increase of locomotor speed, increased explorative behaviour and better coordination outcome on RotaRod. On the other hand the brain tissue damage was bigger and the time of hanging in...
|
Page generated in 0.0522 seconds